Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)
Clinical trial NCT02418481 · COMPLETED
Trial details
- NCT number
- NCT02418481
- Sponsor
- Fuda Cancer Hospital, Guangzhou
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.